The effect of topical corticosteroids, topical antihistamines, and preservatives on human ciliary beat frequency

ORL

Volumn 76, Issue 3, 2014, Pages 127-136

  Jiao, Jian ^a   Meng, Na ^a   Zhang, Luo ^a  

^a BEIJING INSTITUTE OF OTOLARYNGOLOGY   (China)

Author keywords

Ciliary beat frequency; Nasal epithelial cells; Preservatives; Topical antihistamines; Topical corticosteroids

Indexed keywords

ANTIHISTAMINIC AGENT; AZELASTINE; BENZALKONIUM CHLORIDE; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; LEVOCABASTINE; SORBATE POTASSIUM; ALPRENOLOL; BENZALKONIUM; GLUCOCORTICOID; PRESERVATIVE; SORBIC ACID;

ARTICLE; CHRONIC SINUSITIS; CILIARY DYSKINESIA; CILIARY MOTILITY; CILIATED EPITHELIUM; CONTROLLED STUDY; DIGITAL IMAGING; DRUG EFFECT; HUMAN; HUMAN CELL; NOSE MUCOSA; PRIORITY JOURNAL; CELL FUNCTION; CILIARY BEAT FREQUENCY; CILIATED EPITHELIUM CELL; COMPARATIVE STUDY; CORTICOSTEROID THERAPY; CYTOTOXICITY; INVESTIGATIVE PROCEDURES; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; INTRANASAL DRUG ADMINISTRATION; MUCOCILIARY CLEARANCE; PHYSIOLOGY;

ADMINISTRATION, INTRANASAL; BENZALKONIUM COMPOUNDS; CELL CULTURE TECHNIQUES; EPITHELIAL CELLS; GLUCOCORTICOIDS; HISTAMINE ANTAGONISTS; HUMANS; MUCOCILIARY CLEARANCE; NASAL MUCOSA; PRESERVATIVES, PHARMACEUTICAL; SORBIC ACID;

EID: 84902919215     PISSN: 03011569     EISSN: 14230275     Source Type: Journal    
DOI: 10.1159/000363575     Document Type: Article

References (19)

1. Costantino HR, Illum L, Brandt G, et al: Intranasal delivery: physicochemical and therapeutic aspects. mt Pharm 2007;337:1-24.
2. Merkus P, Romeijn SG, Verhoef JC, et al: Classification of cilio-inhibiting effects of nasal drugs. Laryngoscope 2001;111(4 Pt 1):595-602.
3. Antunes MB, Gudis DA, Cohen NA: Epithelium, cilia, and mucus: their importance in chronic rhinosinusitis. Immunol Allergy Clin North Am 2009;29:631-643.
4. Gudis DA, Cohen NA: Cilia dysfunction. Otolaryngol Clin North Am 2010;43:461-472.
5. Jiao J, Meng N, Wang H, et al: The effects of vitamins C and B12 on human nasal ciliary beat frequency. BMC Complement Altern Med 2013; 13:110.
6. Marple B, Roland P, Benninger M: Safety review o f benzalkonium chloride used as a preservative in intranasal solutions: an overview of conflicting data and opinions. Otolaryngol Head Neck Surg 2004;130:131-141.
7. Riechelmann H, Deutschle T, Stuhlmiller A, et al: Nasal toxicity of benzalkonium chloride. Am J Rhinol 2004; 18:29 1-299.
8. Mallants R, Jorissen M, Augustijns P: Effect ofpreservatives on ciliary beat frequency in human nasa l epithelial cell culture: single versus multiple exposure. IntJ Pharm 2007;338:64-69.
9. Hofmann T, Gugatschga M, Koidl B, et al: Influence of preservatives and topical steroids on ciliary beat f requency in vitro. Arch Otolaryngol Head Neck Surg 2004; 130:440-445.
10. Khanvilkar K, Donovan MD, Flanagan DR: Drug transfer through mucus. Adv Drug Deliv Rev 2001;48:173-193
11. Stanley PJ, Wilson R, Greenstone MA, et al: Abnormal nasal mucociliary clearance in patients with rhinitis and its relationship to concomitant chest disease. Br J Dis Chest 1985; 79:77-82.
12. van de Donk HJM: Nasal medication and ciliary movement. Pharma Weekblad Sci Ed 1983; 5:32-33.
13. Verret DL Marple BF: Effect of topical nasal steroid sprays on nasal mucosa and ciliary function. Curr Opin Otolaryngol Head Neck Surg 2005;13:14-18.
14. Baroody FM, Cheng CC, Moylan B, et al: Absence of nasal mucosal atrophy with fluticasone aqueous nasal spray. Arch Otolaryngol Head Neck Surg 2001;127:193-199.
15. Laliberté F, Laliberté MF, Lécart S, et al: Clinical and pathologic methods to assess the long-term safety of nasal corticosteroids. French Triamcinolone Acetonide Study Group. Allergy 2000; 55:718-722.
16. Klossek JM , Laliberté F, Laliberté MF, et al: Local safety of intranasal triamcinolone acetonide: clinical and histological aspects of nasal mucosa in the long-term treatment of perennial allergic rhinitis. Rhinology 2001; 39:17-22.
17. Naclerio RM, Baroody FM, Bidani N, et al: A comparison of nasal clearance after treatment of perennial allergic rhinitis with budesonide and mometasone. Otolaryngol Head Neck Surg 2003;128:220-227.
18. Lindqvist N, Balle VH, Karma P, et al: Long-term safety and efficacy of budesonide nasal aerosol in perennial rhinitis. A 12-month multicentre study. Allergy 1986;41:179-186.
19. Pipkorn U, Pukander J, Suonpaa J, et al: Long-term safety of budesonide nasal aerosol: a 5.5-year follow-up study. Clin Allergy 1988; 18:253-259.